Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech venture capital
Pharma
Does the Q4 M&A binge foreshadow a boom year for deals in 2026?
Of the top 10 biopharma M&A deals of 2025, six came in the fourth quarter. Will the surge continue in 2026? Many industry watchers believe so.
Kevin Dunleavy
Dec 24, 2025 5:00am
Fierce Biotech
Novo Holdings-backed biotech raises $205M to fill gout care gap
Sep 30, 2025 8:00am
Avalyn adds $100M to advance inhaled versions of IPF pills
Jul 22, 2025 10:44am
Trump investment policy could hit US-China biotech dealmaking
Feb 28, 2025 2:45pm
Zomedica reels in $4M for pet drug development
Aug 31, 2016 2:25pm
5AM raises $285M fifth fund to focus on early-stage development
Jun 7, 2016 8:47am
